Sven Ante Lundberg
CIK 1682126 · President, CEO & PEO · last filed 2026-01-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
31
Lifetime Open-Market Net
$466.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QTTB | Director | — | $12.64 | — | $0 | 5 | 2026-01-30 |
| Merus N.V. (MRUS) Delisted | President, CEO & PEO | 0 | $90.00 | $0 | $460.9K | 20 | 2025-12-12 |
| VOR | Director | — | $14.36 | — | $0 | 5 | 2025-05-23 |
| CRISPR Therapeutics AG (PZRX) Delisted | Chief Scientific Officer | 1,010,834 | — | — | $5.6K | 1 | 2017-02-10 |
Recent Filings · Page 4 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-10 | CRISPR Therapeutics AG (PZRX) Delisted | Mixed | +55,617 | $5.6K | EDGAR |
Showing 31–31 of 31
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.